GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » Earnings per Share (Diluted)

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Earnings per Share (Diluted) : $-0.66 (TTM As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is BlackRock Health Sciences Trust II Earnings per Share (Diluted)?

BlackRock Health Sciences Trust II's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was $-0.49. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.66.

BlackRock Health Sciences Trust II's EPS (Basic) for the six months ended in Dec. 2023 was $-0.49. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.66.

BlackRock Health Sciences Trust II's EPS without NRI for the six months ended in Dec. 2023 was $-0.49. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.66.

During the past 3 years, the average EPS without NRIGrowth Rate was -60.30% per year.

During the past 4 years, BlackRock Health Sciences Trust II's highest 3-Year average EPS without NRI Growth Rate was -60.30% per year. The lowest was -60.30% per year. And the median was -60.30% per year.


BlackRock Health Sciences Trust II Earnings per Share (Diluted) Historical Data

The historical data trend for BlackRock Health Sciences Trust II's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II Earnings per Share (Diluted) Chart

BlackRock Health Sciences Trust II Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
11.63 -2.55 -5.97 0.73

BlackRock Health Sciences Trust II Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial -3.03 -6.69 0.66 -0.17 -0.49

Competitive Comparison of BlackRock Health Sciences Trust II's Earnings per Share (Diluted)

For the Asset Management subindustry, BlackRock Health Sciences Trust II's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BlackRock Health Sciences Trust II's PE Ratio Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's PE Ratio distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's PE Ratio falls into.



BlackRock Health Sciences Trust II Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

BlackRock Health Sciences Trust II's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(69.859-0)/95.697
=0.73

BlackRock Health Sciences Trust II's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-52.399-0)/106.514
=-0.49

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


BlackRock Health Sciences Trust II  (NYSE:BMEZ) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BlackRock Health Sciences Trust II Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212